TRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises funds
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Price | 1.50p on 04-07-2025 | at 18:40:05
---|---|
Change | -0.05p -3.23% |
Buy | 1.60p |
Sell | 1.40p |
Buy / Sell CIZ Shares |
Last Trade: | Buy 272,133.00 at 1.56p |
Day's Volume: | 2,446,364 |
Last Close: | 1.50p |
Open: | 1.55p |
ISIN: | GB00BNG2VN02 |
Day's Range | 1.45p - 1.55p |
52wk Range: | 1.40p - 2.65p |
Market Capitalisation: | £6m |
VWAP: | 1.509221p |
Shares in Issue: | 396m |
Sector: Medicine and Biotech
Cizzle Biotech (CIZ) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 272,133 | 1.56p | Ordinary |
16:28:29 - 04-Jul-25 |
Buy* | 31,321 | 1.56p | Ordinary |
16:05:48 - 04-Jul-25 |
Buy* | 17,000 | 1.56p | Ordinary |
15:57:39 - 04-Jul-25 |
Unknown* | 500,000 | 1.57p | Ordinary |
15:53:28 - 04-Jul-25 |
Sell* | 2,421 | 1.42p | Ordinary |
15:51:38 - 04-Jul-25 |
Buy* | 2,791 | 1.57p | Ordinary |
15:47:02 - 04-Jul-25 |
Buy* | 327,310 | 1.52p | Ordinary |
15:38:10 - 04-Jul-25 |
Buy* | 59,210 | 1.52p | Ordinary |
15:22:16 - 04-Jul-25 |
Buy* | 327,049 | 1.52p | Ordinary |
15:20:14 - 04-Jul-25 |
Buy* | 58,687 | 1.52p | Ordinary |
14:48:49 - 04-Jul-25 |
Cizzle Biotech (CIZ) Regulatory News |
||
Date | Source | Headline |
---|---|---|
30th Jun 2025 1:45 pm | RNS | Result of AGM |
6th Jun 2025 11:00 am | RNS | Notice of AGM |
28th May 2025 7:00 am | RNS | Holding(s) in Company |
20th May 2025 7:00 am | RNS | £150,000 Convertible Loan Note Issue |
30th Apr 2025 11:18 am | RNS | Final results for the year ended 31 December 2024 |
28th Apr 2025 7:00 am | RNS | Contract in Caribbean and Update on CIZ1B |
14th Apr 2025 10:00 am | RNS-R | Launch of New Website |
25th Mar 2025 7:00 am | RNS | Appointment of Non-Executive Director |
24th Mar 2025 7:00 am | RNS | Update on Launch of CIZ1B Biomarker Assay |
2nd Jan 2025 7:00 am | RNS | Appointment of Professor Dawn Coverley as CSO |